Duke University

Category

A Political Ping Pong: Duke HERO Study Still Pursuing Question Whether Hydroxychloroquine a Potential Prophylaxis to COVID-19

Meet Michael Waxman, a physician from Kansas City and participant in one of the largest hydroxychloroquine clinical trials in the United States. He also happens to have the honor of being the study’s “truest guinea pig” doing it “gladly and “without reservation.” The...

Rush Medical Center Initiates HERO-HCQ Study in Chicago: Will Hydroxychloroquine Help Protect Healthcare Workers from COVID-19?

Rush University Medical Center opened up enrollment for the HERO-HCQ clinical trial to determine whether hydroxychloroquine is better than a placebo in preventing COVID-19 in healthy people working in a health care setting. With its full title as the Healthcare Worker...

Vanderbilt & Williamson Medical Center of TN Join HERO Study & Accelerate Enrollment of Health Workers for Prevention of COVID-19

Both Vanderbilt Medical Center and Williamson Medical Center have joined the Healthcare Worker Exposure Response and Outcomes (HERO) clinical trial, a federally-supported research effort investigating the effectiveness of plaquenil hydroxychloroquine in preventing the...

University Hospitals Seidman Cancer Center Treats its First Glioblastoma Patient with Duke-Originated Genetically Modified Polio Virus

University Hospitals Seidman Cancer Center (UH) treated its first patient in a new clinical trial to validate groundbreaking effects of poliovirus on glioblastoma (GBM), a deadly Grade IV cancer of the brain. UH was the only Midwest site that participated in this...